Skip Ribbon Commands
Skip to main content

R2V

Radial to Visceral

Research on R2V applied to hepatic interventional oncology, uterine fibroid embolization, prostate artery embolization, renal, and peripheral intervention demonstrated R2V was technically successful in 98.2% of the cases, complication rate (Hematoma and/or bleeding) was 0.86% and the overall complication rate was witnessed in 2.51% of cases.

In addition, the widespread application of R2V to cancer therapy is anticipated to realize lower invasive therapy with higher safety and cost-effectiveness5.

Expand your access and delivery options for therapeutic delivery

RADIFOCUS™ Glidecath™ R.A.V.I.* MG1 and MG2 tip shapes specifically designed for radial access provides you with the performance required for visceral and pelvic interventions.
  • Trackability - Traverse tortuous anatomy while leveraging on its ability to deliver devices through a nylon rich inner layer5,6.
  • Torqueability - Engage acute vessels with good torque control with a double-braided design5,6.
  • Lubricity​ - Navigate difficult vasculature with great lubricity provided by M Coat™ Technology​5,6.

* R.A.V.I : Radial Access for Visceral Intervention

​1. Yamada R et al. J Vasc Interv Radiol 2018 ;29:38-43.
2. Valgimigli M et al. Lancet 2015;385:2465–76.
3. Mamas MA et al. Circ Cardiovasc Qual Outcomes 2018;11:e004482
4. Fishcman AM et al. Tech Vasc Interv Radiol 2015;18:58-65
5. Data on file
6. When compared to leading competitors​



The video hereafter ​is a recording of the webinar 'Beyond cardiology - transradial access and visceral intervention'​ to allow healthcare professionals to watch the event on demand. This recording is to be used for training purposes only and in no case intended for the general public. Any claims and views expressed in this video reflect solely the speaker's own experiences or opinions and do not necessarily reflect the position of Terumo. No part of the recording may be reproduced, distributed, transmitted in any form or by any means, electronic or manually, without the prior written consent of Terumo Europe NV.

Educational support

Radial access is an evolving field, where the global experiences may help you in your daily practice. Discover Best practice in R2V from Prof. Guimaraes, Professor Medical University of South Carolina, US

What the evidence says

Discover our clinical evidence and case studies concerning this topic.

Upcoming events

Mauris sed purus volutpat, convallis nibh ac, feugiat lorem. Sed dignissim arcu eulala.

EUROPCR 2024
May 14 - 17 , France
All events

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.